


apoA-V Antibody (1G5G9) is a mouse monoclonal IgG1 antibody that detects apoA-V in human samples through western blotting (WB) and immunoprecipitation (IP) applications. ApoA-V is a 366 amino acid protein encoded by the human apoA-V gene, and plays a crucial role in lipid metabolism, particularly in regulating plasma triglyceride levels. ApoA-V is primarily synthesized in the liver and secreted into the bloodstream, where apoA-V interacts with lipoproteins to modulate triglyceride levels and influence overall lipid homeostasis. Anti-apoA-V antibody (1G5G9) enhances research into the clearance of triglyceride-rich lipoproteins from circulation, thereby reducing the risk of cardiovascular diseases associated with elevated triglyceride levels. ApoA-V has been shown to interact with other proteins involved in lipid metabolism, such as apolipoprotein C-III, which further underscores apoA-V′s significance in maintaining lipid balance and preventing metabolic disorders. With specificity for human apoA-V, apoA-V monoclonal antibody (1G5G9) serves as an invaluable tool for researchers studying lipid metabolism and related diseases.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
apoA-V Antibody (1G5G9) | sc-32809 | 200 µg/ml | $316.00 | |||
apoA-V Antibody (1G5G9): m-IgG Fc BP-HRP Bundle | sc-536757 | 200 µg Ab; 10 µg BP | $354.00 | |||
apoA-V Antibody (1G5G9): m-IgGκ BP-HRP Bundle | sc-533921 | 200 µg Ab; 40 µg BP | $354.00 | |||
apoA-V Antibody (1G5G9): m-IgG1 BP-HRP Bundle | sc-544801 | 200 µg Ab; 20 µg BP | $354.00 |